Literature DB >> 2784507

Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins.

E Böhnlein1, M Siekevitz, D W Ballard, J W Lowenthal, L Rimsky, H Bogérd, J Hoffman, Y Wano, B R Franza, W C Greene.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) preferentially infects CD4+ T lymphocytes and may exist as a latent provirus within these cells for extended periods. The transition to a productive retroviral infection results in T-cell death and clinically may lead to the acquired immune deficiency syndrome. Accelerated production of infectious HIV-1 virions appears to be closely linked to a heightened state of T-cell activation. The transactivator (Tax) protein of the type I human T-cell leukemia virus (HTLV-I) can produce such an activated T-cell phenotype and augments activity of the HIV-1 long terminal repeat. One Tax-responsive region within the HIV-1 long terminal repeat has been mapped to a locus composed of two 10-base-pair direct repeats sharing homology with the binding site for the eucaryotic transcription factor NF-kappaB (GGGACTTTCC). Tax-expressing Jurkat T cells contain one or more inducible cellular proteins that specifically associate with the HIV-1 enhancer at these binding sites. Microscale DNA affinity precipitation assays identified a Tax-inducible 86-kilodalton protein, HIVEN86A, as one of these HIV-1 enhancer-binding factors. The interaction of HIVEN86A, and presumably other cellular proteins, with the HIV-1 enhancer appears functionally important as oligonucleotides corresponding to this enhancer were sufficient to impart Tax inducibility to an unresponsive heterologous promoter. These findings suggest that the Tax-inducible cellular protein HIVEN86A plays an important role in the transcriptional activation of the HIV-1 enhancer. These specific protein-DNA interactions may also be important for the transition of HIV-1 from a latent to a productive mode of infection. Furthermore, these findings highlight an intriguing biological interplay between HTLV-1 and HIV-1 through a cellular transcriptional pathway that is normally involved in T-cell activation and growth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784507      PMCID: PMC248395     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.

Authors:  J D Mosca; D P Bednarik; N B Raj; C A Rosen; J G Sodroski; W A Haseltine; G S Hayward; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay.

Authors:  B R Franza; S F Josephs; M Z Gilman; W Ryan; B Clarkson
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

3.  Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes.

Authors:  J Inoue; M Yoshida; M Seiki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

4.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

5.  Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I.

Authors:  M Siekevitz; M B Feinberg; N Holbrook; F Wong-Staal; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression.

Authors:  C A Rosen; R Park; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I.

Authors:  S L Cross; M B Feinberg; J B Wolf; N J Holbrook; F Wong-Staal; W J Leonard
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

8.  Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element.

Authors:  J D Kaufman; G Valandra; G Roderiquez; G Bushar; C Giri; M A Norcross
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

9.  Human immunodeficiency virus long terminal repeat responds to T-cell activation signals.

Authors:  S E Tong-Starksen; P A Luciw; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

10.  Alterations in binding characteristics of the human immunodeficiency virus enhancer factor.

Authors:  F Wu; J Garcia; R Mitsuyasu; R Gaynor
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

View more
  42 in total

1.  Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.

Authors:  M L Hammarskjöld; M C Simurda
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 2.  Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.

Authors:  Gerold Feuer; Patrick L Green
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

3.  Mutational analysis of human T-cell leukemia virus type 2 Tax.

Authors:  T M Ross; A C Minella; Z Y Fang; S M Pettiford; P L Green
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Transcriptional activation of RNA polymerase III-dependent genes by the human T-cell leukemia virus type 1 tax protein.

Authors:  J M Gottesfeld; D L Johnson; J K Nyborg
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  Protein kinase A-dependent binding of a nuclear factor to the 21-base-pair repeat of the human T-cell leukemia virus type I long terminal repeat.

Authors:  H T Poteat; F Y Chen; P Kadison; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

Review 6.  Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia.

Authors:  M R Smith; W C Greene
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

7.  Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax.

Authors:  I Lemasson; V Robert-Hebmann; S Hamaia; M Duc Dodon; L Gazzolo; C Devaux
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner.

Authors:  A Schmidt; L Hennighausen; U Siebenlist
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

9.  Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.

Authors:  H C Lin; M Bodkin; R B Lal; A B Rabson
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.

Authors:  R Grassmann; S Berchtold; I Radant; M Alt; B Fleckenstein; J G Sodroski; W A Haseltine; U Ramstedt
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.